Literature DB >> 7429653

Biological activities of C5a and C5adesArg from hog serum.

B Damerau, B Zimmermann, E Grünefeld, K Czorniak, W Vogt.   

Abstract

The complement-derived peptides C5a and C5adesArg (highly purified from yeast-activated hog serum) were both active in the following biological assays: in aggregation of human leukocytes (potency ratio for C5a:C5adesArg 3:1), in aggregation of guinea pig platelets (10:1), in chemotaxis of peritoneal rabbit leukocytes (10:1), and in contraction of isolated guinea pig ileum (1.4:1). The fact that C5adesArg preparations have 30 and 40% of the activity of C5a in leukocyte aggregation and smooth muscle contraction but only 10% of C5a chemotactic activity, clearly indicates that aggregation and spasmogenic activity are inherent properties of C5adesArg. Evidence that C5adesArg owns all activities studied is further given by the following findings: chromatographic separation of mixtures of C5a and C5adesArg results in the appearance of two peaks of spasmogenic activity; treatment of C5adesArg with carbopeptidase B does neither lead to release of detectable arginine nor abrogate any of the biological effects; treatment of C5a with carboxypeptidase B reduces the activities quantitatively to those of C5adesArg, and liberates the theoretically expected amount of arginine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429653     DOI: 10.1159/000232656

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  10 in total

1.  C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.

Authors:  H U Beuscher; V Brade
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

2.  Chemotactic factor-induced polarization, receptor redistribution, and locomotion of human blood monocytes.

Authors:  L N Islam; P C Wilkinson
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

3.  Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model.

Authors:  H G Höllerhage; G F Walter; D Stolke
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg.

Authors:  B Damerau; J Roesler; W Vogt
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

5.  Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).

Authors:  J Sorgenfrei; B Damerau; W Vogt
Journal:  Agents Actions       Date:  1982-04

Review 6.  Activation of the complement system.

Authors:  W Vogt
Journal:  Agents Actions       Date:  1983-08

7.  Anaphylatoxins inhibit C2 production.

Authors:  D Lappin; B Damerau; K Whaley
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes.

Authors:  B Damerau; H Wüstefeld; D Fricke; H Kunze
Journal:  Agents Actions       Date:  1984-12

9.  Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.

Authors:  D Lappin; D W Riches; B Damerau; K Whaley
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

10.  Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.

Authors:  Katharina Bröker; Robin Terzenbach; Frank Bentzien; Stefan Lüth; Werner Dammermann
Journal:  J Transl Med       Date:  2019-01-03       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.